CAS 321-64-2|Tacrine

Introduction:Basic information about CAS 321-64-2|Tacrine, including its chemical name, molecular formula, synonyms, physicochemical properties, and safety information, etc.
Common NameTacrine
CAS Number321-64-2Molecular Weight198.264
Density1.3±0.1 g/cm3Boiling Point353.8±42.0 °C at 760 mmHg
Molecular FormulaC13H14N2Melting Point283-284ºC
MSDS/Flash Point167.8±27.9 °C

Names

Nametacrine
SynonymMore Synonyms

Tacrine BiologicalActivity

DescriptionTacrine is a potent acetylcholinesterse (AChE) inhibitor (IC50=109 nM), also acting as a CYP1A2 substrate drug. Tacrine exhibits certain hepatotoxicity in some individuals. Tacrine can be used for researching Alzheimer's disease (AD)[1][2][3].
Related CatalogResearch Areas >>Neurological DiseaseSignaling Pathways >>Neuronal Signaling >>AChE
Target

IC50: 109 nM (AChE)[3]

References

[1]. Patocka J, et al. Possible role of hydroxylated metabolites of tacrine in drug toxicity and therapy of Alzheimer's disease. Curr Drug Metab. 2008;9(4):332-335.

[2]. Bhatt S, et al. Assessment of the CYP1A2 Inhibition-Mediated Drug Interaction Potential for Pinocembrin Using In Silico, In Vitro, and In Vivo Approaches. ACS Omega. 2022;7(23):20321-20331. Published 2022 Jun 2.

[3]. Romero A, et al. Novel tacrine-related drugs as potential candidates for the treatment of Alzheimer's disease. Bioorg Med Chem Lett. 2013;23(7):1916-1922.

Chemical & Physical Properties

Density1.3±0.1 g/cm3
Boiling Point353.8±42.0 °C at 760 mmHg
Melting Point283-284ºC
Molecular FormulaC13H14N2
Molecular Weight198.264
Flash Point167.8±27.9 °C
Exact Mass198.115692
PSA38.91000
LogP1.78
Vapour Pressure0.0±0.8 mmHg at 25°C
Index of Refraction1.682
InChIKeyYLJREFDVOIBQDA-UHFFFAOYSA-N
SMILESNc1c2c(nc3ccccc13)CCCC2

Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :
AR9532100
CHEMICAL NAME :
Acridine, 1,2,3,4-tetrahydro-9-amino-
CAS REGISTRY NUMBER :
321-64-2
BEILSTEIN REFERENCE NO. :
0147610
LAST UPDATED :
199707
DATA ITEMS CITED :
17
MOLECULAR FORMULA :
C13-H14-N2
MOLECULAR WEIGHT :
198.29
WISWESSER LINE NOTATION :
T C666 BNT&&J IZ

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Human - woman
DOSE/DURATION :
294 mg/kg/14W-I
TOXIC EFFECTS :
Liver - fatty liver degeneration Liver - liver function tests impaired Blood - changes in cell count (unspecified)
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Human - woman
DOSE/DURATION :
84 mg/kg/6W-I
TOXIC EFFECTS :
Liver - hepatitis (hepatocellular necrosis), zonal Liver - liver function tests impaired
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Human - man
DOSE/DURATION :
176 mg/kg/7W-I
TOXIC EFFECTS :
Gastrointestinal - nausea or vomiting Liver - liver function tests impaired
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
70 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
30 mg/kg
TOXIC EFFECTS :
Biochemical - Enzyme inhibition, induction, or change in blood or tissue levels - true cholinesterase
TYPE OF TEST :
LDLo - Lowest published lethal dose
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
20 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intramuscular
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
34 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
39800 ug/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
20 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Subcutaneous
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
25 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intramuscular
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
29 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Unreported
SPECIES OBSERVED :
Mammal - species unspecified
DOSE/DURATION :
31 mg/kg
TOXIC EFFECTS :
Behavioral - euphoria Behavioral - antipsychotic
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
620 mg/kg/18W-C
TOXIC EFFECTS :
Nutritional and Gross Metabolic - weight loss or decreased weight gain
TYPE OF TEST :
Cytogenetic analysis

MUTATION DATA

TEST SYSTEM :
Rodent - mouse
DOSE/DURATION :
100 mg/kg
REFERENCE :
ACNSAX Activitas Nervosa Superior. (Avicenum, Malostranske nam. 28, Prague 1, Czechoslovakia) V.1- 1959- Volume(issue)/page/year: 26,84,1984

Safety Information

Hazard CodesT
Risk PhrasesR25
HS Code2933990090

Customs

HS Code2933990090
Summary2933990090. heterocyclic compounds with nitrogen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%

Synonyms

EINECS 206-291-2
MFCD00046923
9-Acridinamine, 1,2,3,4-tetrahydro-
1,2,3,4-TETRAHYDRO-9-ACRIDINAMINE
9-Amino-1,2,3,4-tetrahydroacridine
Tetrahydroaminocrine
Tenakrin
1,2,3,4-tetrahydro-5-aminoacridine
Cognex
4-Amino-2,3-tetramethylenequinoline
Tetrahydroaminocrin
1,2,3,4-tetrahydro-9-amino-acridine
Tetrahydroaminacrine
1,2,3,4-tetrahdyroacridin-9-amine
1,2,3,4-tetrahydroacridin-9-amine
Romotal
Tetrahydroaminoacridine
Tacrine
CAS 141992-47-4|NSC 625987
CAS 102-02-3|Phenylbiguanide
Recommended......
TOP